Cardiovascular outcomes studies in people with T2D and high cardiovascular risk have shown that DPP4i have an overall cardio-neutral profile32–37, while GLP1-RAs were associated with decreased all-cause mortality and major adverse cardiovascular events (MACE)38. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.